Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options
- 4 February 2023
- journal article
- review article
- Published by Springer Nature in Advances in Therapy
- Vol. 40 (4) , 1357-1365
Abstract
Aminoglycosides are a class of medications used to treat certain bacterial infections, specifically gram-negative aerobes. These drugs can be used alone as first-line treatments or in combination with other medications. There can be many different formulations of aminoglycosides including oral, inhalants, intravascular, intramuscular, or intraventricular. There are many distinctive types of aminoglycosides, and although they provide excellent coverage, they can have a wide variety of side effects. The most prevalent side effects of aminoglycosides are nephrotoxicity and ototoxicity. Aminoglycoside-induced nephrotoxicity is concerning because of the effects that abnormal creatinine levels can have on other drugs and the potential for neurotoxicity. Fortunately, changes in renal function are typically reversible. The kidney is affected by the drug’s ability to enter the proximal tubule and cause a buildup of phospholipids in the lysosomes, inhibiting their function. Exposure to aminoglycosides in utero can result in permanent ototoxicity. The mechanism of ototoxicity is through the drug’s ability to freely pass into hair cells and cause reactive oxygen species to damage the mitochondria, resulting in cell death. There is not a substantial amount of research regarding the prevention and treatment of adverse effects of aminoglycosides. Future research on the mediation or modulation of these pathophysiological processes would expand their usage in modern medicine.Keywords
This publication has 30 references indexed in Scilit:
- Estimation of renal function in the intensive care unit: the covert concepts brought to lightJournal of Intensive Care, 2014
- Accuracy of the estimation of glomerular filtration rate within a population of critically ill patientsJournal Of Nephrology, 2014
- Evaluation of Extended Interval Dosing Aminoglycosides in the Morbidly Obese PopulationAdvances in Pharmacological Sciences, 2013
- Augmented Renal Clearance in the Critically Ill: How to Assess Kidney FunctionAnnals of Pharmacotherapy, 2012
- Recommended dose of arbekacin, an aminoglycoside against methicillin-resistantStaphylococcus aureus, does not achieve desired serum concentration in critically ill patients with lowered creatinine clearanceJournal of Clinical Pharmacy and Therapeutics, 2008
- Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 2004
- Does once-daily dosing prevent nephrotoxicity in all aminoglycosides equally?Clinical Microbiology and Infection, 2000
- Experience with a once-daily aminoglycoside program administered to 2,184 adult patientsAntimicrobial Agents and Chemotherapy, 1995
- Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patientsCritical Care Medicine, 1991
- Aminoglycoside-induced renal phospholipidosis and nephrotoxicityBiochemical Pharmacology, 1990